AGN

It’s Time to Buy AbbVie Stock Now After Its Allergan Purchase

AbbVie stock needed its merger with AGN stock to diversify. Now that it has, the stock has more potential upside thanks to Allergan.

Buy Allergan Stock as Big Pharma’s Biggest Deal Is About to Close

Don't let the pandemic distract your attention from a monster acquisition - and a chance to own AGN stock before the deal's finalized.

The AbbVie Buyout is Not a Sure Thing for Allergan Stock Investors

The coronavirus has completely changed the narrative on AbbVie’s buyout of AGN. Allergan stock holders banking on it should reconsider.

Buy AbbVie Stock as the Drugmaker Diversifies Its Pipeline

With a major acquisition in the works, ABBV stock isn't just a dividend king, but a rapidly-diversifying juggernaut.

Allergan Earnings: AGN Stock Ticks Nearly 2% Higher on Q4 Beat

Allergan (AGN) earnings for the pharmaceutical company's fourth quarter of 2019 have AGN stock up Monday after beating estimates.

Is Amarin Stock a Top Pick for 2020?

Amarin stock has been on fire in 2019, but the reaction to its latest news was discouraging. Is that a buying opportunity or a warning sign?

Stock Market Today: Amazon Breakout?; REIT Hate

Amazon shares are breaking out and investors seem to hate REITs. Here's what happened in the stock market today.

5 Undervalued Stocks to Buy

These undervalued stocks have been hit hard lately, but they still have what it takes to make a comeback, making them solid stocks to buy.

Stock Market Today: General Electric Bears; Disney+ Bonanza

General Electric stock has a bearish analyst, while Disney+ already hits 10 million subs. Here's what happened in the stock market today.

7 Big Biotech Stocks to Watch

Biotech stocks are still out of favor because of macro uncertainties. But beneath that, investors may find companies trading at deep value.

Stock Market Today: How Many Times Will the Fed Cut Rates? 

After six straight sessions of losses, it was a welcomed sight to see stocks rally on Tuesday. Here's what happened on the stock market today.

This Pharmaceutical Company is Oversold and Starting to Recover

This morning, I am recommending a bullish trade on AbbVie, Inc. (NYSE:ABBV), the biopharmaceutical company.

Nasdaq Today: Semis Rally, Micron Earnings, Suing FB and GOOGL?

Trump says that Facebook and Alphabet should be sued, while Micron surged on earnings. Semiconductors got a big boost in the Nasdaq today as well.

Wednesday’s Vital Data: AbbVie, FedEx and Micron

Options trading was buzzing in AbbVie, FedEx and Micron Tuesday. Here are the metrics that matter moving forward.

3 Big Stock Charts for Wednesday: Tyson Foods, Lennar and State Street

The stock charts of TSN, STT and LEN are headed into the midpoint of the week on the verge of major turns.

Nasdaq Today: Hard to Keep Track of the Losers

Biotech rallied on a $63 billion deal between AbbVie and Allergan. But other than that, it was a tough day for the Nasdaq today.

5 Top Stock Trades for Wednesday — AGN, ABBV, FDX, MSFT, BB

AbbVie is buying Allergan, FedEx and Blackberry are reporting earnings and Microsoft is on the move. Here are our top stock trades.

AbbVie-Allergan Deal: AGN Stock Soars on $63 Billion Buyout

News of an AbbVie-Allergan deal has AGG stock heading higher on Tuesday with plans for the former company to acquire the latter.

5 Top Stock Trades for Wednesday: BA, AVGO, ETSY, NIO, AGN

Allergan looks to still be in a downtrend, while Etsy stock is fighting with resistance at $70 and Boeing hurdles the 50-day moving average.